• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C2相关碳水化合物结构对Ig效应子功能的影响:在中国仓鼠卵巢细胞糖基化突变体中使用嵌合小鼠-人IgG1抗体进行的研究。

Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.

作者信息

Wright A, Morrison S L

机构信息

Department of Microbiology and Molecular Genetics, Molecular Biology Institute, University of California, Los Angeles 90095, USA.

出版信息

J Immunol. 1998 Apr 1;160(7):3393-402.

PMID:9531299
Abstract

The complex biantennary oligosaccharide at Asn297 of IgG is essential for some effector functions. To investigate the effect of carbohydrate structure on Ab function, we have now expressed mouse-human chimeric IgG1 Abs in Chinese hamster ovary (CHO) cells with defined defects in carbohydrate biosynthesis. We had previously shown that IgG1 Abs produced in the cell line Lec 1, which attaches a high-mannose intermediate carbohydrate, were severely deficient in complement activation, showed a slightly reduced affinity for Fc gammaRI, and had a reduced in vivo half-life. We have extended these studies by producing the same dansyl-specific IgG1 in cell lines deficient in attachment of sialic acid (Lec 2) and galactose (Lec 8). IgG1-Lec 1, IgG1-Lec 2, and IgG1-Lec 8 all showed varying reactivity with a mAb specific for an epitope in the amino terminal region of C(H)2, suggesting that the conformations of these proteins were altered by the different carbohydrate structures. Functionally, IgG1-Lec 2 and IgG1-Lec 8 were comparable to wild type with respect to in vivo half-life, affinity for Fc gammaRI, and capacity for complement-mediated hemolysis. While IgG1-Lec 2 was essentially identical to wild type in its capacity to interact with individual components of the classical complement activation pathway, IgG1-Lec 8 demonstrated equivalent maximal binding at lower concentrations and was preferentially bound by mannose-binding protein. Although IgG1-Lec 1 was deficient in activation of the classical pathway, it had a superior capacity to activate the alternative pathway. These studies demonstrate that Abs bearing C(H)2-linked carbohydrate of differing structures have different functional properties.

摘要

IgG在Asn297位点的复杂双触角寡糖对于某些效应功能至关重要。为了研究碳水化合物结构对抗体功能的影响,我们现在在中国仓鼠卵巢(CHO)细胞中表达了具有特定碳水化合物生物合成缺陷的小鼠 - 人嵌合IgG1抗体。我们之前已经表明,在附着高甘露糖中间碳水化合物的Lec 1细胞系中产生的IgG1抗体在补体激活方面严重缺陷,对FcγRI的亲和力略有降低,并且体内半衰期缩短。我们通过在缺乏唾液酸(Lec 2)和半乳糖(Lec 8)附着的细胞系中产生相同的丹磺酰特异性IgG1来扩展这些研究。IgG1-Lec 1、IgG1-Lec 2和IgG1-Lec 8与针对C(H)2氨基末端区域表位的单克隆抗体均表现出不同的反应性,这表明这些蛋白质的构象因不同的碳水化合物结构而改变。在功能上,IgG1-Lec 2和IgG1-Lec 8在体内半衰期、对FcγRI的亲和力以及补体介导的溶血能力方面与野生型相当。虽然IgG1-Lec 2在与经典补体激活途径的各个组分相互作用的能力上与野生型基本相同,但IgG1-Lec 8在较低浓度下表现出等效的最大结合能力,并且优先被甘露糖结合蛋白结合。尽管IgG1-Lec 1在经典途径的激活方面存在缺陷,但它具有激活替代途径的更强能力。这些研究表明,带有不同结构的C(H)2连接碳水化合物的抗体具有不同的功能特性。

相似文献

1
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.C2相关碳水化合物结构对Ig效应子功能的影响:在中国仓鼠卵巢细胞糖基化突变体中使用嵌合小鼠-人IgG1抗体进行的研究。
J Immunol. 1998 Apr 1;160(7):3393-402.
2
Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.改变的CH2相关碳水化合物结构对嵌合型小鼠-人免疫球蛋白G1功能特性及体内命运的影响
J Exp Med. 1994 Sep 1;180(3):1087-96. doi: 10.1084/jem.180.3.1087.
3
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.去糖基化嵌合小鼠-人IgG的研究。碳水化合物在人IgG恒定区介导的结构和效应功能中的作用。
J Immunol. 1989 Oct 15;143(8):2595-601.
4
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.具有三种不同N-连接Fc寡糖(高甘露糖型、杂合型和复合型)的非岩藻糖基化治疗性IgG1抗体之间的生物学活性比较。
Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29.
5
Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.IgG与其核心寡糖的多种相互作用可调节补体和人Fcγ受体I的识别,并影响其寡糖链的合成。
J Immunol. 1996 Dec 1;157(11):4963-9.
6
Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.通过减少抗体-白细胞介素2融合蛋白与Fc受体的相互作用来提高其疗效。
Cancer Res. 1999 May 1;59(9):2159-66.
7
Glycobiology: 'the function of sugar in the IgG molecule'.糖生物学:“糖在免疫球蛋白分子中的功能”
J Anat. 1995 Oct;187 ( Pt 2)(Pt 2):279-92.
8
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.GnTIII在重组抗CD20 CHO生产细胞系中的表达:具有改变糖型的抗体的表达通过对FcγRIII的更高亲和力导致ADCC增加。
Biotechnol Bioeng. 2001 Aug 20;74(4):288-94.
9
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.在IgG上添加一个μ尾段会产生具有增强效应功能的多聚体抗体,包括IgG4介导的补体依赖性细胞溶解。
J Immunol. 1995 Mar 1;154(5):2226-36.
10
Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.具有定制效应功能的杂合IgA2/IgG1抗体。
Clin Immunol. 2001 Oct;101(1):21-31. doi: 10.1006/clim.2001.5083.

引用本文的文献

1
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.重组单克隆抗体电荷变体的基于风险的控制策略
Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073.
2
Biosimilar or Not: Physicochemical and Biological Characterization of MabThera and Its Two Biosimilar Candidates.生物类似药与否:美罗华及其两种生物类似药候选药物的理化和生物学特性
ACS Pharmacol Transl Sci. 2021 Mar 12;4(2):790-801. doi: 10.1021/acsptsci.0c00225. eCollection 2021 Apr 9.
3
A rapid method for relative quantification of -glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development.
治疗性单克隆抗体曲妥珠单抗生物类似药开发过程中 - 聚糖的相对定量的快速方法。
MAbs. 2020 Jan-Dec;12(1):1750794. doi: 10.1080/19420862.2020.1750794.
4
Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.探讨补体在预测、预防和治疗溶血性输血反应中的作用。
Transfus Med Rev. 2019 Oct;33(4):217-224. doi: 10.1016/j.tmrv.2019.09.006. Epub 2019 Oct 18.
5
Model-Driven Engineering of N-Linked Glycosylation in Chinese Hamster Ovary Cells.中国仓鼠卵巢细胞中N-糖基化的模型驱动工程
ACS Synth Biol. 2019 Nov 15;8(11):2524-2535. doi: 10.1021/acssynbio.9b00215. Epub 2019 Oct 18.
6
Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies.天然和重组IgG抗体的宏观和微观异质性
Antibodies (Basel). 2019 Feb 19;8(1):18. doi: 10.3390/antib8010018.
7
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life.调节抗体效应功能和循环半衰期的概念方法。
Front Immunol. 2019 Jun 7;10:1296. doi: 10.3389/fimmu.2019.01296. eCollection 2019.
8
Structure, heterogeneity and developability assessment of therapeutic antibodies.治疗性抗体的结构、异质性和可开发性评估。
MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17.
9
Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.糖基化对均一糖型糖基化 IgG1 单克隆抗体效应功能和热稳定性的影响。
MAbs. 2019 Feb/Mar;11(2):350-372. doi: 10.1080/19420862.2018.1551044. Epub 2018 Dec 10.
10
Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies.治疗性抗体设计中的药代动力学和药效学考虑因素。
Clin Transl Sci. 2019 Mar;12(2):130-139. doi: 10.1111/cts.12597. Epub 2018 Dec 27.